These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2405612)

  • 1. Restenosis following coronary angioplasty.
    Fanelli C; Aronoff R
    Am Heart J; 1990 Feb; 119(2 Pt 1):357-68. PubMed ID: 2405612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restenosis rate after multiple percutaneous transluminal coronary angioplasty procedures at the same site. A quantitative angiographic study in consecutive patients undergoing a third angioplasty procedure for a second restenosis.
    Bauters C; Mc Fadden EP; Lablanche JM; Quandalle P; Bertrand ME
    Circulation; 1993 Sep; 88(3):969-74. PubMed ID: 8353924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restenosis following coronary angioplasty.
    Karas SP; Santoian EC; Gravanis MB
    Clin Cardiol; 1991 Oct; 14(10):791-801. PubMed ID: 1954687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
    Hermans WR; Rensing BJ; Foley DP; Tijssen JG; Rutsch W; Emanuelsson H; Danchin N; Wijns W; Chappuis F; Serruys PW
    J Cardiovasc Pharmacol; 1993; 22 Suppl 4():S45-57. PubMed ID: 7523772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Restenosis after coronary angioplasty: status in 1994].
    Vojácek J
    Vnitr Lek; 1995 May; 41(5):325-31. PubMed ID: 7653063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphologic changes during follow-up after successful percutaneous transluminal coronary balloon angioplasty: quantitative angiographic analysis in 778 lesions--further evidence for the restenosis paradox. MERCATOR Study Group (Multicenter European Research trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis).
    Hermans WR; Foley DP; Rensing BJ; Serruys PW
    Am Heart J; 1994 Mar; 127(3):483-94. PubMed ID: 8122593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in restenosis propensity of devices for transluminal coronary intervention. A quantitative angiographic comparison of balloon angioplasty, directional atherectomy, stent implantation and excimer laser angioplasty. CARPORT, MERCATOR, MARCATOR, PARK, and BENESTENT Trial Groups.
    Foley DP; Melkert R; Umans VA; de Jaegere PP; Strikwerda S; de Feyter PJ; Serruys PW
    Eur Heart J; 1995 Oct; 16(10):1331-46. PubMed ID: 8746901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Southwestern internal medicine conference: restenosis: the Achilles heel of coronary angioplasty.
    Lange RA; Willard JE; Hillis LD
    Am J Med Sci; 1993 Oct; 306(4):265-75. PubMed ID: 8213896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restenosis after coronary angioplasty for rapidly progressive coronary stenosis.
    Bauters C; Passart F; Lablanche JM; McFadden EP; Hamon M; Bertrand ME
    Eur Heart J; 1996 Nov; 17(11):1671-7. PubMed ID: 8922915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restenosis after delayed coronary angioplasty of the culprit vessel in patients with a recent myocardial infarction treated by thrombolysis.
    Bauters C; Khanoyan P; McFadden EP; Quandalle P; Lablanche JM; Bertrand ME
    Circulation; 1995 Mar; 91(5):1410-8. PubMed ID: 7867181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transoesophageal pacing echocardiography for detection of restenosis after percutaneous transluminal coronary angioplasty.
    Hoffmann R; Kleinhans E; Lambertz H; Flachskampf FA; Uebis R; Buell U; Hanrath P
    Eur Heart J; 1994 Jun; 15(6):823-31. PubMed ID: 8088272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Luminal narrowing after percutaneous transluminal coronary angioplasty. A multivariate analysis of clinical, procedural and lesion related factors affecting long-term angiographic outcome in the PARK study. Post-Angioplasty Restenosis Ketanserin.
    Melkert R; Violaris AG; Serruys PW
    J Invasive Cardiol; 1994 Jun; 6(5):160-71. PubMed ID: 10155065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of restenosis after coronary balloon angioplasty: rationale and design of the Fluvastatin Angioplasty Restenosis (FLARE) Trial. The FLARE Study Group.
    Foley DP; Bonnier H; Jackson G; Macaya C; Shepherd J; Vrolix M; Serruys PW
    Am J Cardiol; 1994 May; 73(14):50D-61D. PubMed ID: 8198025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Restenosis after percutaneous transluminal coronary angioplasty].
    Haze K
    Kokyu To Junkan; 1989 Dec; 37(12):1283-93. PubMed ID: 2616905
    [No Abstract]   [Full Text] [Related]  

  • 15. Restenosis after percutaneous transluminal coronary angioplasty.
    Pedersen HK; Vatne K; Simonsen S
    Acta Radiol; 1992 Mar; 33(2):149-51. PubMed ID: 1562409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Identification of predictive factors associated with recurrent restenosis after second percutaneous transluminal coronary angioplasty].
    Kishi K; Hiasa Y; Tanaka H; Kinoshita M; Tanimoto M; Wada T; Aihara T
    J Cardiol; 1997 Jan; 29(1):7-12. PubMed ID: 9023674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and angiographic outcome in patients with in-stent restenosis and repeat target lesion revascularisation in small coronary arteries.
    Gross CM; Krämer J; Weingärtner O; Uhlich F; Dietz R; Waigand J
    Heart; 2000 Sep; 84(3):307-13. PubMed ID: 10956297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of early radionuclide angiography for identifying low-risk patients for late restenosis after percutaneous transluminal coronary angioplasty.
    O'Keefe JH; Lapeyre AC; Holmes DR; Gibbons RJ
    Am J Cardiol; 1988 Jan; 61(1):51-4. PubMed ID: 2962485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restenosis following coronary angioplasty: clinical presentations and therapeutic options.
    Levine GN; Chodos AP; Loscalzo J
    Clin Cardiol; 1995 Dec; 18(12):693-703. PubMed ID: 8608668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of PAI-1 plasma activity and thallium perfusion imaging for restenosis after percutaneous transluminal angioplasty in clinically asymptomatic patients.
    Gottsauner-Wolf M; Sochor H; Hornykewycz S; Beckmann R; Lang I; Probst P; Binder BR; Huber K
    Thromb Haemost; 1999 Apr; 81(4):522-6. PubMed ID: 10235432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.